CUTANEOUS MARKERS OF INSULIN RESISTANCE AND METABOLIC SYNDROME: DIAGNOSTIC VALUE AND IMPLICATIONS FOR EARLY INTERVENTION - A NARRATIVE REVIEW

Authors

DOI:

https://doi.org/10.31435/ijitss.4(52).2026.6873

Keywords:

Acanthosis Nigricans, Insulin Resistance, Metabolic Syndrome, Obesity, Skin Manifestations

Abstract

Background: Insulin resistance and metabolic syndrome may remain clinically silent, while selected cutaneous findings are visible during routine examination. Their associations with metabolic abnormalities vary, and they are not diagnostic tests.

Objective: To summarize evidence linking selected skin findings with insulin resistance and metabolic syndrome and outline a cautious approach to metabolic assessment in dermatology and primary care.

Methods: A targeted narrative search of PubMed, Google Scholar and reference lists identified English-language guidelines, reviews, observational studies and relevant case series available through 31 October 2026. Search concepts covered insulin resistance, metabolic syndrome, acanthosis nigricans, acrochordons, xanthomas and related dermatoses. Evidence was synthesized qualitatively.

Results: Acanthosis nigricans has the clearest association with hyperinsulinemia and obesity-related metabolic risk, but diagnostic performance varies across populations and study designs. Multiple acrochordons are associated with dysglycemia and metabolic-syndrome components but are nonspecific. Eruptive xanthomas may signal severe hypertriglyceridemia. Hidradenitis suppurativa and psoriasis are associated with cardiometabolic comorbidity, while acne, hirsutism and female-pattern hair loss require consideration of hyperandrogenism and polycystic ovary syndrome. No single skin sign establishes or excludes insulin resistance or metabolic syndrome.

Conclusions: Selected skin findings can prompt risk assessment and guideline-based testing, particularly alongside central adiposity or other risk factors. They are clinical cues, not validated stand-alone tests. Prospective studies with standardized definitions are needed.

References

Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., et al. (2009). Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation, 120(16), 1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644

Grundy, S. M., Cleeman, J. I., Daniels, S. R., et al. (2005). Diagnosis and management of the metabolic syndrome: An american heart association/national heart, lung, and blood institute scientific statement. Circulation, 112(17), 2735–2752. https://doi.org/10.1161/CIRCULATIONAHA.105.169404

Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G. (2011). Metabolic syndrome: Definitions and controversies. BMC Med, 9, 48. https://doi.org/10.1186/1741-7015-9-48

Grundy, S. M. (2016). Metabolic syndrome update. Trends Cardiovasc Med, 26(4), 364–373. https://doi.org/10.1016/j.tcm.2015.10.004

Higgins, S. P., Freemark, M., & Prose, N. S. (2008). Acanthosis nigricans: A practical approach to evaluation and management. Dermatol Online J, 14(9), 2. https://doi.org/10.5070/D37MF6G290

Napolitano, M., Megna, M., & Monfrecola, G. (2015). Insulin resistance and skin diseases. ScientificWorldJournal, 2015, 479354. https://doi.org/10.1155/2015/479354

Ponte, P., et al. (2017). Skin manifestations of insulin resistance: From a biochemical stance to a clinical diagnosis and management. Dermatol Ther (Heidelb), 7(1), 63–76. https://doi.org/10.1007/s13555-016-0160-3

Yosipovitch, G., DeVore, A., & Dawn, A. (2007). Obesity and the skin: Skin physiology and skin manifestations of obesity. J Am Acad Dermatol, 56(6), 901–916. https://doi.org/10.1016/j.jaad.2006.12.004

Shipman, A. R. & Millington, G. W. M. (2011). Obesity and the skin. Br J Dermatol, 165(4), 743–750. https://doi.org/10.1111/j.1365-2133.2011.10393.x

Muniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008). Current approaches for assessing insulin sensitivity and resistance in vivo: Advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab, 294(1), E15–E26. https://doi.org/10.1152/ajpendo.00645.2007

Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004). Use and abuse of homa modeling. Diabetes Care, 27(6), 1487–1495. https://doi.org/10.2337/diacare.27.6.1487

Phiske, M. M. (2014). An approach to acanthosis nigricans. Indian Dermatol Online J, 5(3), 239–249. https://doi.org/10.4103/2229-5178.137765

Das, A., et al. (2022). Acanthosis nigricans: A review. J Clin Aesthet Dermatol, 15(11), 18–25. https://pubmed.ncbi.nlm.nih.gov/36698243/

Burke, J. P., Hale, D. E., Hazuda, H. P., & Stern, M. P. (1999). A quantitative scale of acanthosis nigricans. Diabetes Care, 22(10), 1655–1659. https://doi.org/10.2337/diacare.22.10.1655

Nguyen, T. T., Keil, M. F., Russell, D. L., et al. (2001). Relation of acanthosis nigricans to hyperinsulinemia and insulin sensitivity in overweight african american and white children. J Pediatr, 138(4), 474–480. https://doi.org/10.1067/mpd.2001.112617

Kong, A. S., Williams, R. L., Smith, M., et al. (2007). Acanthosis nigricans and diabetes risk factors: Prevalence in young persons seen in southwestern US primary care practices. Ann Fam Med, 5(3), 202–208. https://doi.org/10.1370/afm.678

Kluczynik, C. E. N., et al. (2012). Acanthosis nigricans and insulin resistance in overweight children and adolescents. An Bras Dermatol, 87(4), 531–537. https://doi.org/10.1590/S0365-05962012000400002

Ng, H. Y., et al. (2014). Acanthosis nigricans in obese chinese children. Pediatr Int, 56(3), E1–E5. https://pubmed.ncbi.nlm.nih.gov/24762331/

Das, A., et al. (2023). Association of acanthosis nigricans with metabolic syndrome: An analytic cross-sectional study. An Bras Dermatol, 98(4), 463–470. https://doi.org/10.1016/j.abd.2022.07.006

Gillespie, J., Roland-McGowan, J., Diehl, K., et al. (2026). Is acanthosis nigricans a marker for metabolic syndrome? A systematic review. Am J Clin Dermatol, 27(5), 945–957. https://doi.org/10.1007/s40257-026-01058-7

Sari, R., et al. (2010). The metabolic profile in patients with skin tags. Clin Exp Med, 10(3), 193–197. https://doi.org/10.1007/s10238-009-0086-5

Senel, E., Salmanoğlu, M., Solmazgül, E., & Berçik İnal, B. (2013). Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: A case-control study. J Eur Acad Dermatol Venereol, 27(12), 2637–2643. https://doi.org/10.1111/j.1468-3083.2011.04396.x

Tamega, A. A., Aranha, A. M. P., Guiotoku, M. M., Miot, L. D. B., & Miot, H. A. (2010). Association between skin tags and insulin resistance. An Bras Dermatol, 85(1), 25–31. https://doi.org/10.1590/S0365-05962010000100003

Erdogan, B. S., et al. (2012). Association between acrochordons and the components of metabolic syndrome. J Dermatol, 39(2), 150–155. https://doi.org/10.1111/j.1346-8138.2011.01373.x

Kahana, M., Grossman, E., Feinstein, A., et al. (1987). Skin tags: A cutaneous marker for diabetes mellitus. Acta Derm Venereol, 67(2), 175–177. https://pubmed.ncbi.nlm.nih.gov/2437704/

Parker, F. (1985). Xanthomas and hyperlipidemias. J Am Acad Dermatol, 13(1), 1–30. https://doi.org/10.1016/S0190-9622(85)70134-6

Mija, L. A., Bergeron, C., Abi Chahine, C., et al. (2025). Clinical features and treatment outcomes of eruptive xanthomatosis: A systematic review. J Cutan Med Surg, 29(4), 399–400. https://doi.org/10.1177/12034754251316304

Lee, A., et al. (2016). Xanthelasma palpebrarum and cardiovascular risk factors: A systematic review and meta-analysis. J Am Acad Dermatol, 75(3), 593–600. https://pubmed.ncbi.nlm.nih.gov/27372515/

Garg, A., et al. (2018). Metabolic syndrome and cardiovascular disease among patients with hidradenitis suppurativa: A population-based study. J Am Acad Dermatol, 78(2), 291–297. https://doi.org/10.1016/j.jaad.2017.09.052

Sabat, R., et al. (2020). Hidradenitis suppurativa. Nat Rev Dis Primers, 6, 18. https://doi.org/10.1038/s41572-020-0149-1

Alikhan, A., et al. (2019). North american clinical management guidelines for hidradenitis suppurativa: Part i: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol, 81(1), 76–90. https://doi.org/10.1016/j.jaad.2019.02.067

Takeshita, J., Grewal, S., Langan, S. M., et al. (2017). Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol, 76(3), 377–390. https://doi.org/10.1016/j.jaad.2016.07.064

Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2012). The association between psoriasis and obesity: A systematic review and meta-analysis of observational studies. Nutr Diabetes, 2, e54. https://doi.org/10.1038/nutd.2012.26

Elmets, C. A., Leonardi, C. L., Davis, D. M. R., et al. (2019). Joint aad-npf guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol, 80(4), 1073–1113. https://doi.org/10.1016/j.jaad.2018.11.058

Teede, H. J., Tay, C. T., Laven, J. J. E., et al. (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril, 120(4), 767–793. https://doi.org/10.1016/j.fertnstert.2023.07.025

Legro, R. S., Arslanian, S. A., Ehrmann, D. A., et al. (2013). Diagnosis and treatment of polycystic ovary syndrome: An endocrine society clinical practice guideline. J Clin Endocrinol Metab, 98(12), 4565–4592. https://doi.org/10.1210/jc.2013-2350

Carmina, E., Azziz, R., Bergfeld, W., et al. (2019). Female pattern hair loss and androgen excess: A report from the multidisciplinary androgen excess and PCOS committee. J Clin Endocrinol Metab, 104(7), 2875–2891. https://doi.org/10.1210/jc.2018-02548

American Diabetes Association Professional Practice Committee (2026). 2. Diagnosis and classification of diabetes: Standards of care in diabetes—2026. Diabetes Care, 49(Suppl 1). https://doi.org/10.2337/dc26-S002

US Preventive Services Task Force (2021). Screening for prediabetes and type 2 diabetes: US preventive services task force recommendation statement. JAMA, 326(8), 736–743. https://doi.org/10.1001/jama.2021.12531

International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: International Diabetes Federation; 2006. https://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html

Sado, A., Tomaszewska, M., Wójcik, S., & Rulkiewicz, A. (2026). Skin as a metabolic organ: Dermatologic markers of morbid obesity and their role in risk stratification and treatment monitoring. Diagnostics, 16(9), 1314. https://doi.org/10.3390/diagnostics16091314

Downloads

Published

2026-11-12

How to Cite

Abramchuk, O., Tetarchuk, V., Tetarchuk, V., Tanko, A., Trutsko, A., Shchebetun, A., & Shchebetun, D. (2026). CUTANEOUS MARKERS OF INSULIN RESISTANCE AND METABOLIC SYNDROME: DIAGNOSTIC VALUE AND IMPLICATIONS FOR EARLY INTERVENTION - A NARRATIVE REVIEW. International Journal of Innovative Technologies in Social Science, 1(4(52). https://doi.org/10.31435/ijitss.4(52).2026.6873

Most read articles by the same author(s)

1 2 > >>